Akoya Biosciences, Inc. (AKYA)
NASDAQ: AKYA · Real-Time Price · USD
2.990
-0.010 (-0.33%)
Jan 30, 2025, 4:00 PM EST - Market closed
Akoya Biosciences Market Cap
Akoya Biosciences has a market cap or net worth of $148.22 million as of January 30, 2025. Its market cap has decreased by -41.69% in one year.
Market Cap
148.22M
Enterprise Value
193.85M
1-Year Change
-41.69%
Ranking
Category
Stock Price
$2.99
Market Cap Chart
Since the IPO on April 16, 2021, Akoya Biosciences's market cap has decreased from $713.79M to $148.22M, a decrease of -79.23%. That is a compound annual growth rate of -33.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 29, 2025 | 148.72M | 31.03% |
| Dec 31, 2024 | 113.50M | -52.61% |
| Dec 29, 2023 | 239.49M | -34.07% |
| Dec 30, 2022 | 363.24M | -36.24% |
| Dec 31, 2021 | 569.65M | -20.19% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 724.02B |
| UnitedHealth Group | 495.21B |
| Novo Nordisk | 376.62B |
| Johnson & Johnson | 363.91B |
| AbbVie | 309.71B |
| Merck & Co. | 248.61B |
| Abbott Laboratories | 221.77B |
| Thermo Fisher Scientific | 217.35B |